A Phase 2b Clinical Study of JDB0131 Benzenesulfonate Tablets

NCT07170800 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Tuberculosis
Multidrug Resistant Pulmonary Tuberculosis
Rifampicin-resistant Tuberculosis

Interventions

DRUG: JDB0131 100mg
DRUG: JDB0131 200mg
DRUG: Delamanid (D)

Sponsor

WestVac Biopharma Co., Ltd.